uniQure (QURE) Depreciation & Amortization (CF) (2016 - 2026)
uniQure (QURE) recorded quarterly Depreciation & Amortization (CF) of $3.0 million in Q1 2026, little changed quarter-over-quarter from $3.0 million in Q4 2025, and down 34.7% on a YoY basis from $4.5 million in Q1 2025.
uniQure (QURE) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
uniQure's Depreciation & Amortization (CF) history runs 11 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 34.7% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $13.2 million (down 9.29% YoY), while the FY2025 annual figure was $14.8 million, up 16.76% from the prior year.
- Depreciation & Amortization (CF) was $3.0 million for Q1 2026 at uniQure, roughly flat from $3.0 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $4.5 million in Q1 2025 to a low of $2.0 million in Q2 2022.
- Historically, Depreciation & Amortization (CF) has averaged $3.0 million across 5 years, with a median of $2.7 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Depreciation & Amortization (CF) soared 79.67% in 2023, then plunged 34.7% in 2026.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.3 million in 2022, then jumped by 79.67% to $4.2 million in 2023, then rose by 4.01% to $4.4 million in 2024, then slumped by 31.82% to $3.0 million in 2025, then dropped by 0.47% to $3.0 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $3.0 million (Q1 2026), $3.0 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1,395.22 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 55.90 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 429,663.65 |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 2.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.96 Mn |
| Mar 31, 2026 | 2.96 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | 3.63 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Dec 31, 2024 | 4.36 Mn |
| Dec 31, 2024 | 4.36 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Sep 30, 2024 | 2.99 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 4.19 Mn |
| Dec 31, 2023 | 4.19 Mn |